iCo Therapeutics Inc. announced that Andrew Rae has resigned from his roles as both President & CEO and Director. Mr. Rae has agreed to assist management, through to the end of the fiscal quarter, to ensure a smooth and orderly transition. iCo also announced that Susan Koppy will immediately assume the role of President and William Jarosz will immediately assume the role of & CEO.

Ms. Koppy has served on the iCo Board of Directors (the "Board") since 2015 and has more than 30 years of experience in marketing and business development in the US, Europe and Japan. Mr. Jarosz is the current Chairman of the Board and a founding partner of Cartesian Capital Group. The Board has also announced that Peter Hnik, Chief Medical Officer of iCo, has been appointed as a director of the company.